(Q46511868)

English

Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats

scientific article published in July 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/9767428

Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/9767428

experimental autoimmune encephalomyelitis

1 reference

based on heuristic

inferred from title

author name string

Li HL

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/9767428

Liu JQ

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/9767428

Bai XF

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/9767428

vn der Meide PH

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/9767428

Link H

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/9767428

publication date

1 July 1998

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/9767428

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/9767428

94

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/9767428

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/9767428

431-437

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/9767428

A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00526.X

21 January 2018

Oral tolerance: immune mechanisms and treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00526.X

21 January 2018

Peripheral deletion of antigen-reactive T cells in oral tolerance.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00526.X

21 January 2018

Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00526.X

21 January 2018

Antigen-driven bystander suppression after oral administration of antigens

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00526.X

21 January 2018

Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00526.X

21 January 2018

Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00526.X

21 January 2018

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00526.X

21 January 2018

The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppres

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00526.X

21 January 2018

Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00526.X

21 January 2018

Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00526.X

21 January 2018

Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00526.X

21 January 2018

Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00526.X

21 January 2018

The role of nasopharyngeal lymphoid tissue

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00526.X

21 January 2018

Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00526.X

21 January 2018

Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00526.X

21 January 2018

Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00526.X

21 January 2018

Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00526.X

21 January 2018

Interleukin-10 prevents experimental allergic encephalomyelitis in rats.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.1998.00526.X

21 January 2018

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antigen-specific immunotherapy of autoimmune disease: a commentary

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

29 Production and assay of antibodies to acetylcholine receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defence against allergic sensitization in the healthy lung: the role of inhalation tolerance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure and function of bronchus-associated lymphoid tissue (BALT).

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transforming growth factors beta 1 and beta 2: cytokines with identical immunosuppressive effects and a potential role in the regulation of autoimmune T cell function

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4,

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Organ-specific autoantigens induce transforming growth factor-beta mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of Interferon-γ, Interleukin-4, and Transforming Growth Factor-β in Rats Orally Tolerized against Experimental Autoimmune Myasthenia Gravis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of T-cell responses by feeding peptides containing major and cryptic epitopes: studies with the Der p I allergen

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TGF-beta 2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-10 fails to abrogate experimental autoimmune encephalomyelitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of T cell function in mucosal tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/9767428

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1046/J.1365-2567.1998.00526.X

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/9767428

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/9767428

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46511868&oldid=2119206477"